Article Details
Retrieved on: 2022-09-08 18:25:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
4. Adbry, a high-affinity human monoclonal antibody, was approved by the U.S. Food and Drug Administration (FDA) in December 2021 for the treatment ...
Article found on: www.valdostadailytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here